![]() |
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park
Clin Mol Hepatol. 2024;30(3):487-499. Published online 2024 May 7 DOI: https://doi.org/10.3350/cmh.2024.0145
|
Citations to this article as recorded by
Dietary quality, perceived health, and psychological status as key risk factors for newly developed metabolic dysfunction–associated steatotic liver disease in a longitudinal study
Xuangao Wu, Ting Zhang, Sunmin Park
Nutrition.2025; 130: 112604. CrossRef A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis
Jeayeon Park, Goh Eun Chung, Yoosoo Chang, So Eun Kim, Won Sohn, Seungho Ryu, Yunmi Ko, Youngsu Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gut and Liver.2025; 19(1): 126. CrossRef Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jiatong Xu, Yifan Li, Zixuan Feng, Hongping Chen
Cells.2025; 14(3): 221. CrossRef
|